Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
OCDX was delisted on the 26th of May, 2022.
140 hedge funds and large institutions have $4.31B invested in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in 2021 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 71 increasing their positions, 22 reducing their positions, and 3 closing their positions.
1,167% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 3
223% more repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 22
143% more call options, than puts
Call options by funds: $2.35M | Put options by funds: $966K
32% more funds holding
Funds holding: 106 → 140 (+34)
13% less capital invested
Capital invested by funds: $4.95B → $4.31B (-$639M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$81.9M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$63.4M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$48.3M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$37.7M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$36.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CG
Carlyle Group
Washington,
District of Columbia
|
-$509M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$26.4M |
| 3 |
DKCM
Davidson Kempner Capital Management
New York
|
-$15.1M |
| 4 |
EP
Eversept Partners
New York
|
-$9.65M |
| 5 |
Millennium Management
New York
|
-$5.55M |
OCDX Hedge Fund Activity: Q3 2021 in Review
140 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) for Q3 2021, worth a combined $4.31B — down 13% from $4.95B a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new OCDX positions and 3 closed out — a net gain of 35 holders — while 71 added to existing stakes and 22 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $81.9M. The largest seller was Carlyle Group, cutting an estimated $509M.
- 140 institutional investors held Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) as of Q3 2021, up from 106 in Q2 2021.
- Funds reported $4.31B of Ortho Clinical Diagnostics Holdings plc Ordinary Shares stock for Q3 2021, down 13% quarter-over-quarter.
- 38 funds opened new Ortho Clinical Diagnostics Holdings plc Ordinary Shares positions in Q3 2021 and 3 closed out, a net change of +35 holders.
- The largest Ortho Clinical Diagnostics Holdings plc Ordinary Shares buyer in Q3 2021 was T. Rowe Price Associates, an estimated $81.9M added.
- The largest Ortho Clinical Diagnostics Holdings plc Ordinary Shares seller in Q3 2021 was Carlyle Group, an estimated $509M sold.
Based on aggregated 13F filings for Q3 2021.